LDLR and atherosclerosis: We herein aimed to assess whether treatment with the specific VEGFR-3 agonist VEGF-C 152s could rescue lymphatic function before the onset of atherosclerosis in 3-month-old pre-atherosclerotic Ldlr−/−; hApoB100+/+ mice.